scholarly journals Clinical Characteristics and Risk of Second Primary Lung Cancer After Cervix Cancer: A Population-Based Study

2020 ◽  
Author(s):  
Chengyuan Qian ◽  
Hong Liu ◽  
Yan Feng ◽  
Shenglan Meng ◽  
Dong Wang ◽  
...  

AbstractBackgroundLung cancer as a second primary malignancy is increasingly common, but the clinical characteristics of second primary non-small cell lung cancer after cervix cancer (CC-NSCLC) in comparison with first primary non-small cell lung cancer (NSCLC1) is unknown.MethodsThe Surveillance, Epidemiology and EndResults (SEER) cancer registry between 1998 and 2010 was used to conduct a large population-based cohort analysis. Demographic and clinical characteristics as well as prognostic data were systematically analyzed. We further compared overall survival (OS) in the two cohorts. Risk factors of secondary primary lung cancer in cervical cancer patients were also analyzed.Results557 (3.52%) had developed second primary lung cancer after cervix cancer and 451 were eligible for inclusion in the final analyses. In comparison to NSCLC1, patients with CC-NSCLC had a higher rate of squamous cell carcinoma (SCC) (36.59% vs. 19.07%, p<0.01). Median OS was longer for CC-NSCLC than for NSCLC1 before propensity score matching (PSM) (16 vs. 13months) but there was no significant difference after PSM. High-risk factors in cervical cancer to developing CC-NSCLC include: 50-79years old, black race (OR 1.417; 95%CI 1.095-1.834; p<0.05)and history of radiotherapy (OR 1.392; 95%CI 1.053-1.841; p<0.05).Conclusion50-79years old, black race and history of radiotherapy were independent risk factors of second primary lung cancer in cervical cancer patient. CC-NSCLC patients had distinctive clinical characteristics and a better prognosis compared with NSCLC1 patients.

PLoS ONE ◽  
2020 ◽  
Vol 15 (8) ◽  
pp. e0231807
Author(s):  
Chengyuan Qian ◽  
Hong Liu ◽  
Yan Feng ◽  
Shenglan Meng ◽  
Dong Wang ◽  
...  

Head & Neck ◽  
2012 ◽  
Vol 34 (12) ◽  
pp. 1782-1788 ◽  
Author(s):  
Michael T. Milano ◽  
Carl R. Peterson ◽  
Hong Zhang ◽  
Deepinder P. Singh ◽  
Yuhchyau Chen

2020 ◽  
Author(s):  
Mingfang Xu ◽  
Chengyuan Qian ◽  
Hong Liu ◽  
Yan Feng ◽  
Dong Wang ◽  
...  

Abstract Background: As cervix cancer survival improves, the risk of developing a second cancer has become more important in particular lung cancer. However, the proportion of second primary non-small cell lung cancer after cervix cancer (CC-NSCLC) and associated clinical characteristics are unknown in comparison with first primary non-small cell lung cancer (NSCLC1). Methods: The Surveillance, Epidemiology and End Results (SEER) cancer registry was used to conduct a large population-based cohort analysis of 16768 patients diagnosed with cervical cancer and 173272 patients diagnosed with NSCLC1 between 1998 and 2010. The analysis included demographic, clinical characteristics, prognostic data and risk factors for CC-NSCLC. Results: 557 (3.3%) patients developed CC-NSCLC and 451 were eligible for inclusion in the final analyses. The mean age at CC-NSCLC diagnosis was 62.9 years old. In comparison to NSCLC1, patients with CC-NSCLC had a higher rate of squamous cell carcinoma (36.59% vs 19.07%) and were more likely to be diagnosed in young, unmarried and black subgroups. Median survival time was longer for CC-NSCLC than NSCLC-1 before but not propensity score matching. Localized stage, adenocarcinoma, young age, surgical records, no radiotherapy records and well differentiation were associated with better prognosis in CC-NSCLC cohort. Conclusion: Patients with cervical cancer are at high risk of developing second primary lung cancers. High-risk factors include squamous carcinoma, 50-70years old, black, divorce, history of chemo-radiation therapy and poor differentiation. Prevention in this population as regards the increased risk for second primary cancers is crucial in order to improve the prognosis of patients.


2019 ◽  
Vol 133 (11) ◽  
pp. 974-979 ◽  
Author(s):  
M Adams ◽  
G Gray ◽  
A Kelly ◽  
F Toner ◽  
R Ullah

AbstractObjectiveTo analyse the incidence of second primary lung cancer following treatment for laryngeal cancer and to identify risk factors for its development.MethodRetrospective case series.ResultsThe five-year actuarial incidence of second primary lung cancer was 8 per cent (1.6 per cent per year). This was associated with a very poor median survival of seven months following diagnosis. Supraglottic tumours were associated with an increased risk of second primary lung cancer compared to glottic tumours in both univariate (hazard ratio = 4.32, p = 0.005) and multivariate analyses (hazard ratio = 4.14, p = 0.03).ConclusionSecond primary lung cancer occurs at a rate of 1.6 per cent per year following a diagnosis of laryngeal cancer, and this is associated in a statistically significant manner with supraglottic primary tumour. The recent National Lung Cancer Screening Trial suggests a survival advantage of 20 per cent at five years with annual screening using low-dose computed tomography scanning of the chest in a comparable cohort to ours. These findings have the potential to inform post-treatment surveillance protocols in the future.


Sign in / Sign up

Export Citation Format

Share Document